Renal involvement in primary Sjögren's syndrome (SS). The prevalence of renal SS, its presentation, likely pathogenesis and treatment is reviewed in this article. PubMed, Rheumatology (Oxford), 2015 Sep;54(9):1541-8. (Also see Sjögren's Syndrome and B Cells And T Cells)
Nocturia in Patients With Sleep-Disordered Breathing (SDB) and Cardiovascular Disease (CVD). Continuous positive airway pressure has the potential to reduce nocturia and risk factors for SDB, which may be beneficial in older men with CVD and obstructive sleep apnea. PubMed, Circ J, 10/19/2015. (Also see Cardiac (Heart) Involvement and Sleep Apnea)
The relationship between oxidative stress and autoimmunity in Hashimoto's thyroiditis (HT). The results suggest that oxidative stress increases continuously during the development of subclinical hypothyroidism and overt hypothyroidism in patients with HT. PubMed, Eur J Endocrinol, 2015 Dec;173(6):791-9. (Also see Hashimoto's Thyroiditis)
Ocular Involvement in Systemic Autoimmune Diseases. The aim of this review is to elucidate to non-ophthalmologists the major ocular complications of rheumatic diseases and their specific management and treatment options. PubMed, Clin Rev Allergy Immunol, 10/22/2015. (Also see Systemic Autoimmune Rheumatic Diseases and Eye Involvement of Rheumatic Diseases)
Can creatine supplementation improve body composition and objective physical function in rheumatoid arthritis patients? In patients with RA, creatine supplementation increased muscle mass, but not strength or objective physical function. PubMed, Arthritis Care Res (Hoboken), 09/28/2015. (Also see Treatments for Rheumatoid Arthritis)
Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis. A genetically determined IL-6-dominated RA responds less well to anti-tumor necrosis factorore and work has to be done to provide reliable information regarding the functional aspects of these genetic polymorphisms. PubMed, Clin Rheumatol, 11/03/2015. (Also see Interleukins)
Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence. This review examines the basic epidemiologic principles of identifying risk factors and reviews the evidence to date about risk factors for PsA among patients with psoriasis. PubMed, Curr Rheumatol Rep, 2015 Oct;17(10):64. (Also see Psoriasis and Psoriatic Arthritis)
Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus (SLE) and Sjögren's syndrome (pSS). Functional LILRA3 is a new susceptibility factor for SLE and pSS and it highly predisposes to certain phenotypes such as leucopenia, thrombocytopenia and autoantibody-positive subphenotypes. PubMed, Ann Rheum Dis, 2015 Nov;74(11):2070-5. (Also see Research on Systemic Lupus Erythematosus and Sjögren's Syndrome Research)
Cardiac abnormalities in adult patients with polymyositis (PM) or dermatomyositis (DM) as assessed by non-invasive modalities. Patients with PM or DM had an increased prevalence of cardiac abnormalities compared to healthy controls and left ventricular diastolic dysfunction was a common occurrence and correlated to disease duration. PubMed, Arthritis Care Res (Hoboken), 10/26/2015. (Also see Dermatomyositis and Polymyositis and Complications with Heart Involvement)
Epidemiology of primary Sjögren's syndrome (pSS): a systematic review and meta-analysis. Incidence and prevalence rates of pSS vary widely around the world and these results help us better understand the global epidemiology of pSS. PubMed, Ann Rheum Dis, 2015 Nov;74(11):1983-9. (Also see Sjögren's Syndrome)
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Juliet Youkhana; and donations in loving memory of Jim Miller and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: